Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial

Int J Cardiol. 2015:186:261-3. doi: 10.1016/j.ijcard.2015.03.267. Epub 2015 Mar 20.

Authors

Affiliations

¹ VA North Texas Health Care System, University of Texas Southwestern Medical School, Dallas, TX, United States.
² VA North Texas Health Care System, University of Texas Southwestern Medical School, Dallas, TX, United States. Electronic address: esbrilakis@gmail.com.

PMID: 25828130
DOI: 10.1016/j.ijcard.2015.03.267

No abstract available

Keywords: BMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SVG, saphenous vein graft.

Publication types

Letter
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Aged
Antineoplastic Agents, Phytogenic / pharmacology
Coronary Artery Disease / surgery*
Drug-Eluting Stents*
Female
Follow-Up Studies
Graft Occlusion, Vascular / surgery*
Humans
Male
Paclitaxel / pharmacology*
Percutaneous Coronary Intervention / methods*
Saphenous Vein / transplantation*
Time Factors

Substances

Antineoplastic Agents, Phytogenic
Paclitaxel